Barclays has begun coverage on shares of AmSurg, according to a Corvus Business report.
Here are four points:
1. The brokerage issued an equal weight rating and an $85 price objective on the stock.
2. The stock's 50-day moving average is $79.60 and its 200-day moving average is $77.75.
3. AmSurg stock has a 12-month low of $52.42 and a 12-month high of $87.42.
4. The stock has a market capitalization of $3.43 billion.